Published in Proc Natl Acad Sci U S A on June 23, 1998
Chemical genetics: ligand-based discovery of gene function. Nat Rev Genet (2000) 3.64
Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis. Genetics (2002) 2.71
Production of cyclic peptides and proteins in vivo. Proc Natl Acad Sci U S A (1999) 2.42
Novel protein kinases Ark1p and Prk1p associate with and regulate the cortical actin cytoskeleton in budding yeast. J Cell Biol (1999) 1.79
"Mutagenesis" by peptide aptamers identifies genetic network members and pathway connections. Proc Natl Acad Sci U S A (1999) 1.18
Intracellular expression of Peptide fusions for demonstration of protein essentiality in bacteria. Antimicrob Agents Chemother (2003) 0.93
Isolation of peptide aptamers that inhibit intracellular processes. Proc Natl Acad Sci U S A (2000) 0.93
Yeast and human genes that affect the Escherichia coli SOS response. Proc Natl Acad Sci U S A (1999) 0.90
The eleven-year switch of peptide aptamers. J Biol (2008) 0.84
Oligonucleotide-conjugated beads for transdominant genetic experiments. Nucleic Acids Res (2000) 0.78
A potentially general method for the in vivo selection of inhibitory peptides targeted at a specific protein using yeast. Curr Genet (2008) 0.77
Genetic selection for modulators of a retinoic-acid-responsive reporter in human cells. Genetics (2003) 0.77
Selection systems based on dominant-negative transcription factors for precise genetic engineering. Nucleic Acids Res (2010) 0.76
Dse1 may control cross talk between the pheromone and filamentation pathways in yeast. Curr Genet (2009) 0.76
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics (1989) 105.30
A novel genetic system to detect protein-protein interactions. Nature (1989) 43.83
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell (1993) 33.20
A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene (1987) 25.43
A simple and efficient method for direct gene deletion in Saccharomyces cerevisiae. Nucleic Acids Res (1993) 21.52
Genetic and physical maps of Saccharomyces cerevisiae. Nature (1997) 21.48
Crystal structure of the Aequorea victoria green fluorescent protein. Science (1996) 16.81
Functional inactivation of genes by dominant negative mutations. Nature (1987) 13.12
Improved green fluorescence. Nature (1995) 12.65
Primary structure of the Aequorea victoria green-fluorescent protein. Gene (1992) 11.16
MAP kinase pathways in yeast: for mating and more. Cell (1995) 7.56
A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae. Microbiol Rev (1987) 7.00
Mutants of Saccharomyces cerevisiae unresponsive to cell division control by polypeptide mating hormone. J Cell Biol (1980) 6.94
Mutations affecting sexual conjugation and related processes in Saccharomyces cerevisiae. II. Genetic analysis of nonmating mutants. Genetics (1974) 5.75
Cold-sensitive cell-division-cycle mutants of yeast: isolation, properties, and pseudoreversion studies. Genetics (1982) 4.66
Isolation and genetic analysis of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a factor and alpha factor pheromones. Mol Cell Biol (1982) 4.54
Identification of a gene necessary for cell cycle arrest by a negative growth factor of yeast: FAR1 is an inhibitor of a G1 cyclin, CLN2. Cell (1990) 4.27
Yeast alpha factor is processed from a larger precursor polypeptide: the essential role of a membrane-bound dipeptidyl aminopeptidase. Cell (1983) 4.24
Constitutive mutants of the protein kinase STE11 activate the yeast pheromone response pathway in the absence of the G protein. Genes Dev (1992) 3.65
The carboxy-terminal segment of the yeast alpha-factor receptor is a regulatory domain. Cell (1988) 3.42
Physiological characterization of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a factor and alpha factor pheromones. Mol Cell Biol (1982) 3.37
Modulation of Ras and a-factor function by carboxyl-terminal proteolysis. Science (1997) 3.25
Specific association between the human DNA repair proteins XPA and ERCC1. Proc Natl Acad Sci U S A (1994) 3.19
Order of action of components in the yeast pheromone response pathway revealed with a dominant allele of the STE11 kinase and the multiple phosphorylation of the STE7 kinase. Genes Dev (1992) 2.85
Protein-protein interactions in the yeast pheromone response pathway: Ste5p interacts with all members of the MAP kinase cascade. Genetics (1994) 2.83
Large scale identification of genes involved in cell surface biosynthesis and architecture in Saccharomyces cerevisiae. Genetics (1997) 2.81
FUS3 represses CLN1 and CLN2 and in concert with KSS1 promotes signal transduction. Proc Natl Acad Sci U S A (1991) 2.79
The proliferation of MAP kinase signaling pathways in yeast. Curr Opin Cell Biol (1995) 2.60
Complexes between STE5 and components of the pheromone-responsive mitogen-activated protein kinase module. Proc Natl Acad Sci U S A (1994) 2.53
Role for the Rho-family GTPase Cdc42 in yeast mating-pheromone signal pathway. Nature (1995) 2.48
Pheromone signalling in Saccharomyces cerevisiae requires the small GTP-binding protein Cdc42p and its activator CDC24. Mol Cell Biol (1995) 2.31
Overexpression of the STE4 gene leads to mating response in haploid Saccharomyces cerevisiae. Mol Cell Biol (1990) 2.21
CDC45, a novel yeast gene that functions with the origin recognition complex and Mcm proteins in initiation of DNA replication. Mol Cell Biol (1997) 2.17
Dominant genetics using a yeast genomic library under the control of a strong inducible promoter. Proc Natl Acad Sci U S A (1992) 2.14
An extensive deletion causing overproduction of yeast iso-2-cytochrome c. Cell (1981) 2.08
The pheromone response pathway in Saccharomyces cerevisiae. Annu Rev Genet (1993) 2.03
Pheromone response elements are necessary and sufficient for basal and pheromone-induced transcription of the FUS1 gene of Saccharomyces cerevisiae. Mol Cell Biol (1991) 1.96
Cloning mammalian genes by expression selection of genetic suppressor elements: association of kinesin with drug resistance and cell immortalization. Proc Natl Acad Sci U S A (1994) 1.93
Association of the yeast pheromone response G protein beta gamma subunits with the MAP kinase scaffold Ste5p. Science (1995) 1.88
Mutation of RGA1, which encodes a putative GTPase-activating protein for the polarity-establishment protein Cdc42p, activates the pheromone-response pathway in the yeast Saccharomyces cerevisiae. Genes Dev (1995) 1.77
Green fluorescent protein as a scaffold for intracellular presentation of peptides. Nucleic Acids Res (1998) 1.67
Molecular cloning and characterization of the STE7 and STE11 genes of Saccharomyces cerevisiae. Mol Cell Biol (1985) 1.61
Protein phosphatase type 1 interacts with proteins required for meiosis and other cellular processes in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.54
Dominant negative selection of heterologous genes: isolation of Candida albicans genes that interfere with Saccharomyces cerevisiae mating factor-induced cell cycle arrest. Proc Natl Acad Sci U S A (1992) 1.46
Cloning of Saccharomyces cerevisiae STE5 as a suppressor of a Ste20 protein kinase mutant: structural and functional similarity of Ste5 to Far1. Mol Gen Genet (1993) 1.42
STE50, a novel gene required for activation of conjugation at an early step in mating in Saccharomyces cerevisiae. Mol Gen Genet (1992) 1.29
Identification of Cdc45p, an essential factor required for DNA replication. Gene (1997) 1.28
Human CPR (cell cycle progression restoration) genes impart a Far- phenotype on yeast cells. Genetics (1997) 1.25
Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments. Nucleic Acids Res (1992) 1.23
Interactions among the subunits of the G protein involved in Saccharomyces cerevisiae mating. Mol Cell Biol (1993) 1.12
Ste50p sustains mating pheromone-induced signal transduction in the yeast Saccharomyces cerevisiae. Mol Microbiol (1996) 1.11
Cloning of the STE5 gene of Saccharomyces cerevisiae as a suppressor of the mating defect of cdc25 temperature-sensitive mutants. Proc Natl Acad Sci U S A (1993) 1.06
Identification of a new class of negative regulators affecting sporulation-specific gene expression in yeast. Genetics (1997) 0.86
Published criteria for evaluating health related web sites: review. BMJ (1999) 8.04
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
Access to health information and support: a public highway or a private road? JAMA (1998) 4.86
Molecular characterization of Shaker, a Drosophila gene that encodes a potassium channel. Cell (1987) 3.16
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet (1995) 2.11
Complex structure and regulation of the P16 (MTS1) locus. Cancer Res (1995) 1.87
Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat Genet (1996) 1.74
Green fluorescent protein as a scaffold for intracellular presentation of peptides. Nucleic Acids Res (1998) 1.67
Organization of the transcriptional unit of a human class II histocompatibility antigen: HLA-DR heavy chain. Nucleic Acids Res (1983) 1.65
Escherichia coli open reading frame 696 is idi, a nonessential gene encoding isopentenyl diphosphate isomerase. J Bacteriol (1999) 1.64
Multiple patterns of resistance of human leukemia cell sublines to amsacrine analogues. J Natl Cancer Inst (1990) 1.57
Translating health psychology into effective health communication: the american healthstyles audience segmentation project. J Health Psychol (1996) 1.52
Novel surface antigen expressed on dividing cells but absent from nondividing cells. J Exp Med (1980) 1.50
Efficient, automatic detection of heterozygous bases during large-scale DNA sequence screening. Biotechniques (1995) 1.44
A P1-based physical map of the region from D17S776 to D17S78 containing the breast cancer susceptibility gene BRCA1. Hum Mol Genet (1994) 1.34
Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene (1995) 1.12
Graded mode of transcriptional induction in yeast pheromone signalling revealed by single-cell analysis. Yeast (2001) 1.09
Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res (1997) 1.03
Humoral immunity in scid mice reconstituted with cells from immunoglobulin-deficient or normal humans. Immunol Rev (1991) 0.98
Living-donor liver transplantation at UCLA. Am J Surg (1995) 0.95
Suicide gene therapy for plasma cell tumors. Blood (1996) 0.90
Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc Natl Acad Sci U S A (1994) 0.89
Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines. Br J Cancer (1991) 0.88
Early graft function after pediatric liver transplantation: comparison between in situ split liver grafts and living-related liver grafts. Transplantation (2001) 0.88
Human potassium channel genes: Molecular cloning and functional expression. Mol Cell Neurosci (1990) 0.88
Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. J Natl Cancer Inst (1995) 0.88
A review of inherited predisposition to melanoma. Semin Oncol (1996) 0.87
Reversible, p16-mediated cell cycle arrest as protection from chemotherapy. Cancer Res (1996) 0.86
Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171. Genomics (1994) 0.86
Heterogeneity of a human T-lymphoblastoid cell line. Exp Cell Res (1987) 0.83
High molecular weight antigens present on human T cells. Proc Natl Acad Sci U S A (1980) 0.82
Comparative analysis of Homo sapiens and Mus musculus cyclin-dependent kinase (CDK) inhibitor genes p16 (MTS1) and p15 (MTS2). J Mol Evol (1995) 0.81
Template selection during manipulation of complex mixtures by PCR. Biotechniques (2001) 0.80
Genetic predisposition to melanoma. Eur J Cancer (1994) 0.79
Creation of a stable human reporter cell line suitable for FACS-based, transdominant genetic selection. Somat Cell Mol Genet (1999) 0.79
Oligonucleotide-conjugated beads for transdominant genetic experiments. Nucleic Acids Res (2000) 0.78
Response. Science (1994) 0.78
Expression of ion channels in cultured cells using baculovirus. Methods Enzymol (1992) 0.78
Cellular dialogs during development. Cell (1989) 0.78
Monitoring the efficacy of hybrid selection during positional cloning: the search for BRCA1. Mamm Genome (1995) 0.77
A genetic selection method for expression products that induce apoptosis in adherent mammalian cell lines. Apoptosis (2003) 0.77
Exogenous peptide and protein expression levels using retroviral vectors in human cells. Mol Ther (2001) 0.77
Absence of HTLV I from New Zealand. J Med Virol (1987) 0.76
Retroviral-mediated gene transfer into human bone marrow stromal cells: studies of efficiency and in vivo survival in SCID mice. Eur J Haematol (1995) 0.76
Review of published criteria for evaluating health-related websites. West J Med (1999) 0.75
Transcriptional transactivation by selected short random peptides attached to lexA-GFP fusion proteins. BMC Mol Biol (2001) 0.75
Cancer. Sun protection factor p53. Nature (1995) 0.75
Enrichment during transdominant genetic experiments using a flow sorter. Cytometry (2001) 0.75
Response. Science (1995) 0.75
Characterization of the hepatic and splenic immune status and immunoglobulin synthesis in aged male mice lacking the peroxisome proliferator-activated receptor-alpha (PPARα). Scand J Immunol (2011) 0.75
'MHC' nomenclature. Nature (1979) 0.75
T-cell leukaemia not confirmed. N Z Med J (1986) 0.75
Identification of the gltX gene encoding glutamyl-tRNA synthetase from Methanobacterium thermoautotrophicum. Biochim Biophys Acta (1996) 0.75
The SCID mouse as a model for autoimmunity. J Autoimmun (1993) 0.75
Semipreparative electrophoresis with prestained proteins. Anal Biochem (1979) 0.75